RESEARCH ARTICLE

Antioxidant, anti-inflammatory, and antibacterial activities of a 70% ethanol-Symphyocladia linearis extract

Jeong Min Lee1,https://orcid.org/0000-0002-9593-1849, Mi-Jin Yim1,https://orcid.org/0000-0002-2086-1823, Hyun-Soo Kim1https://orcid.org/0000-0003-4703-6978, Seok-Chun Ko1https://orcid.org/0000-0002-0509-3336, Ji-Yul Kim1https://orcid.org/0000-0002-9638-7179, Gun-Woo Oh1https://orcid.org/0000-0003-0494-2508, Kyunghwa Baek1https://orcid.org/0000-0002-3754-0989, Dae-Sung Lee1,*https://orcid.org/0000-0003-0627-1402
Author Information & Copyright
1National Marine Biodiversity Institute of Korea, Seocheon 33662, Korea

#These authors contributed equally to this work.

*Corresponding author: Dae-Sung Lee, National Marine Biodiversity Institute of Korea, Seocheon 33662, Korea, Tel: +82-41-950-0620, Fax: +82-41-950-0621, E-mail:daesung@mabik.re.kr

Copyright © 2022 The Korean Society of Fisheries and Aquatic Science. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Sep 29, 2022; Revised: Oct 24, 2022; Accepted: Oct 29, 2022

Published Online: Nov 30, 2022

Abstract

Research on the potential biological activity of red alga Symphyocladia spp. has been limited to Symphyocladia latiuscula, which is widely used as a food ingredient in Korea. Here, we examined the biological activity of another species, Symphyocladia linearis, which is found in Korea and was reported as a new species in 2013. The aim of this study was to evaluate the antioxidant, anti-inflammatory, and antibacterial properties of a 70% ethanol extract of S. linearis. Antioxidant activity, which was evaluated using radical scavenging assays, revealed half maximal inhibitory concentration values for 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) and 2,2′-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) of 34.57 and 11.70 μg/mL algal extract, respectively. Anti-inflammatory activity of the S. linearis ethanolic extract was evaluated using RAW 264.7 cells by measuring the inhibition of lipopolysaccharide-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production. The potential cytotoxicity of NO and PGE2 was first examined, confirming no toxicity at concentrations ranging from 10-100 μg/mL. NO production was inhibited 61.1% and 78.0% at 50 and 100 μg/mL S. linearis extract, respectively; and PGE2 production was inhibited 69.1%, 83.2%, and 94.8% at 25, 50, and 100 μg/mL S. linearis extract, respectively. Thus, the S. linearis extract showed very strong efficacy against PGE2 production. The cellular production of reactive oxygen species, measured using 2′,7′-dichlorofluorescin diacetate fluorescence, was inhibited 48.8% by the addition of 100 μg/mL S. linearis extract. Antibacterial activity was evaluated using the disc diffusion method and minimum inhibitory concentration (MIC). S. linearis was effective only against gram-positive bacteria, exhibiting antibacterial activity against Staphylococcus aureus with a MIC of 256 μg/mL extract and against Bacillus cereus with a MIC of 1,024 μg/mL extract. Based on these results, we infer that a 70% ethanolic extract of S. linearis possesses strong anti-inflammatory properties, and therefore has the potential to be used in the prevention and treatment of inflammatory and immune diseases.

Keywords: Anti-inflammatory; Antioxidant; Antibacterial; Symphyocladia linearis

Introduction

The genus Symphyocladia belongs to the family Rhodomelaceae and comprises several species of red algae. Seven Symphyocladia species (Symphyocladia linearis, Symphyocladia marchantioides, Symphyocladia glabra, Symphyocladia pumila, Symphyocladia lithophila, Symphyocladia jejuinsula, and Symphyocladia latiuscula) are known to inhabit Korean coasts (Kang & Kim, 2013). Among the seven species, S. latiuscula has been extensively studied for various biological activities, including anti-tyrosinase (Paudel et al., 2019c), anti-Alzheimer’s (Paudel et al., 2019b), anti-diabetic (Paudel et al., 2019a), antifungal (Xu et al., 2014), antiviral (Park et al., 2005), antioxidative (Zhang et al., 2007), and anti-aldose reductase activity (Wang et al., 2005). In addition, S. latiuscula has been registered as a food ingredient in Korea (Ministry of Food and Drug Safety) and is widely used industrially.

When subjected to environment stress (e.g., UV light, air pollution, ionizing radiation, smoke), reactive oxygen species (ROS) are generated, such as hydroxyl, superoxide, and lipid radicals. ROS induce lipid peroxidation and can damage DNA and proteins. Antioxidant enzymes, such as superoxide dismutase and peroxidase, help protect cells from oxidative stress, but if this system does not work properly and ROS cannot be removed, various conditions may develop, including high blood pressure, cancer, and diabetes (Lee, 2021). Several methods, such as oxygen radical absorbance capacity, hydroxyl radical antioxidant capacity, total peroxyl radical trapping antioxidant parameter, cupric ion reducing antioxidant capacity, ferric reducing antioxidant power, 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH), and 2,2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), are used to measure antioxidant activity as determined by their ability to scavenge ROS (Munteanu & Apetrei, 2021).

The inflammatory response is an immune response that restores damaged tissues from external stimuli such as stress and injury. Inflammation is regulated by inflammatory mediators and cytokines secreted from macrophages, and synthesis of inflammatory factors such as nitric oxide (NO) and prostaglandin E2 (PGE2) may be induced by lipopolysaccharide (LPS) and reactive nitrogen species (Cho et al., 2009). When the production of inflammatory mediators increases, diseases such as diabetes, cancer, and atherosclerosis can develop; thus, it is important to suppress the generation of these inflammatory mediators (Liu et al., 2016; Yu et al., 2016).

Bacterial infection and the development of resistant bacteria continue to be serious concerns worldwide, necessitating the development of new antibacterial agents (Moghadamtousi et al., 2014). Staphylococcus aureus, Escherichia coli, Bacillus cereus, and Salmonella typhimurium are well known food-borne pathogens (Al-Zoreky, 2009; Kanatt et al., 2010). Research to identify marine algal extracts that are active against these bacteria is being actively conducted (Shannon & Abu-Ghannam, 2016). To date, research on Symphyocladia has been limited to S. latiuscula. Therefore, we examined another species, S. linearis, to determine its biological activity and potential use as an antioxidative, anti-inflammatory, or antibacterial agent.

Materials and Methods

Algal material and extraction

S. linearis specimens were collected in April 2018 from Gangneung-si city, Gangwon-do province, Korea, and deposited at the National Marine Biodiversity Institute of Korea (MABIK).

Freeze-dried whole seaweed of S. linearis (30 g) was extracted by sonication using 70% ethanol (EtOH; 300 mL × 3) for 1 h, and evaporated to dryness by heating under reflux in vacuo. The dried 70% EtOH S. linearis extract (3.16 g dry weight) was stored at –80°C until biological activity assessment.

Cell culture and cell viability assay

RAW 264.7 macrophages (ATCC, USA) were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 μg/mL) in a humidified incubator with 5% CO2 at 37°C.

To assess cell viability, 100 μL of RAW 264.7 macrophages was seeded in triplicate at a density of 3 × 105 cells/mL in wells of a 96-well plate and cultured for 20–24 h. After removing the DMEM, 10 μL of S. linearis extract in 80 μL of fresh medium was added to each well and the samples were incubated for 30 min. Subsequently, 10 μL of LPS was added and the samples were incubated for 20–24 h. Finally, 10 μL of Cell Counting Kit-8 reagent (Dojindo Laboratories, Japan) was added and the samples were allowed to react for 2 h. Thereafter, the sample absorbance in each well was measured at 450 nm using a microplate reader.

Measurement of antioxidant activity

A slightly modified version of a method described by Blois (1958) was used to measure the DPPH radical scavenging activity of the S. linearis extract. Specifically, 100 µL of various concentrations (10–100 μg dry weight extract/mL) of the S. linearis extract was added to 100 µL of a 150 μM DPPH solution in a 96-well plate. The plate was shaken vigorously and placed in the dark at room temperature for 30 min, after which the absorbance of each sample was measured at 516 nm. The DPPH radical scavenging activity of the S. linearis extract was calculated and expressed as the half maximal inhibitory concentration (IC50) value.

The ABTS radical scavenging activity of the S. linearis extract was measured using a slightly modified version of a method described by Re et al. (1999). ABTS•+ was produced by mixing a 7 mM aqueous stock solution of ABTS•+ with 2.45 mM potassium peroxodisulfate in the dark at 4°C for 16 h. The stock solution was diluted with EtOH to an absorbance of 0.700 ± 0.100 at a wavelength of 734 nm. Various concentrations (10–100 μg dry weight extract/mL) of the S. linearis extract (100 µL) were added to wells containing 100 μg/mL of ABTS•+ solution in a 96-well plate. The plate was shaken vigorously and placed in the dark at room temperature for 15 min. The absorbance was then measured at 734 nm against a blank test.

The inhibition of ROS generation by the S. linearis extract was measured using a method described by Lee et al. (2021). RAW 264.7 cells were cultured in 96-well plates (3 × 105 cells/mL) and incubated at 37°C for 24 h. The cells were then incubated with 5 μM 2',7'-dichlorofluorescin diacetate (DCFH-DA) for 30 min in the dark, treated with various concentrations (10–100 μg dry weight extract/mL) of the S. linearis extract, and incubated again for 30 min. The cells were then exposed to 10 μg/mL LPS for 24 h. ROS production was measured by recording the fluorescence at an excitation/emission wavelength of 492/525 nm using a fluorescence microplate reader.

Measurement of anti-inflammatory activity

Inhibition of NO production by the S. linearis extract was measured using a method described by Lee et al. (2021). RAW 264.7 cells were plated in 12-well plates (3 × 105 cells/mL) and upon confluency they were treated with various concentrations (10–100 μg/mL) of the S. linearis extract and 100 μg/mL LPS for 24 h. Thereafter, the NO produced was measured using the Griess reagent kit (Invitrogen, USA). The absorbance of each sample well was measured at 548 nm using a microplate reader and inhibition of NO production by the S. linearis extract was expressed as a percentage (%) of the LPS-stimulated group value.

Inhibition of PGE2 production by the S. linearis extract was measured using a method described by Lee et al. (2021). RAW 264.7 cells were plated in 12-well plates (3 × 105 cells/mL) and upon confluency they were treated with various concentrations of the S. linearis extract (10–100 μg/mL) and 100 μg/mL LPS for 24 h. Thereafter, PGE2 production was measured using a PGE2 high sensitivity enzyme immunosorbent assay kit (Enzo, Japan). The absorbance of each sample well was measured at 405 nm using a microplate reader and inhibition of PGE2 production by the S. linearis extract was expressed as a percentage (%) of the LPS-stimulated group value.

Measurement of antibacterial activity

The antibacterial activity of the S. linearis extract was tested against four reference microbial strains (S. aureus ATCC 6538P, B. cereus ATCC 14579, E. coli KCTC 2571, and S. typhimurium KCTC 1925) using the disc diffusion method and calculating the minimum inhibitory concentration (MIC) of the extract. A bacterial suspension (1 × 108 CFU/mL) was spread on Müeller Hinton Agar plates. An aliquot of S. linearis extract was then placed on the paper discs in the inoculated plates. The plates were allowed to stand for 15 min at room temperature, after which they were incubated at 35 ± 2°C for 16–18 h. The diameters of the inhibition zones were measured in millimeters and all tests were performed in triplicate. To evaluate the MIC of the S. linearis extract, the extract was diluted in each liquid medium, the concentration of the test bacteria was measured by suspending it at a concentration of 2–8 × 105 CFU/mL, and the test bacteria was serially diluted two-fold in Müeller Hinton broth. Thus, the concentration range was determined. After incubation at 35 ± 2°C for 16–20 h, the minimum concentration of algal extract at which no bacterial growth was observed was determined to be the MIC.

Statistical analysis

All data in this study are presented as means ± SD of triplicate experiments and analyzed using SPSS (PASW statistics 18). A p < 0.05 was considered statistically significant.

Results

Antioxidant activity

The potential cytotoxicity of the S. linearis extract was measured in cell experiments, revealing that a concentration range of 10–100 μg dry weight extract/mL did not reduce the viability of LPS-stimulated RAW 264.7 cells (Fig. 1A). Therefore, a concentration range of 10–100 μg/mL extract was chosen for subsequent experiments. The IC50 values for DPPH and ABTS of the S. linearis extract were 34.57 and 11.70 μg/mL, respectively (Table 1). The inhibition of ROS production by the S. linearis extract was 12.8%, 38.2%, 49.3%, and 48.8% at 10, 25, 50, and 100 μg/mL, respectively (Fig. 1B). The S. linearis extract demonstrated greater antioxidant activity than the LPS-treated (control) group at all concentrations of extract.

fas-25-11-579-g1
Fig. 1. Effect of Symphyocladia linearis extract (10–100 μg/mL) on cell viability (A) and production of ROS (B). RAW 264.7 cells were pretreated with different concentrations of S. linearis extract (10–100 μg/mL) and then exposed to LPS. All data are expressed as a percentage (%) of the NT. The experiment was performed in triplicate and data are presented as mean ± SD. ***p <0.001 versus the LPS-stimulated group. NT, untreated control; LPS, lipopolysaccharide; ROS, reactive oxygen species.
Download Original Figure
Table 1. DPPH and ABTS radical scavenging activity of Symphyocladia linearis extract expressed as the IC50
Sample DPPH (IC50) ABTS (IC50)
S. linearis extract (μg/mL) 34.57 ± 0.361) 11.70 ± 0.05

1) Data are expressed as the mean ± SD (n = 3).

IC50, half-maximal inhibitory concentration.

Download Excel Table
Anti-inflammatory activity

The anti-inflammatory activity of the S. linearis extract was evaluated based on inhibition of NO and PGE2 production in LPS-stimulated RAW 264.7 cells. S. linearis extract inhibited NO production by 10.0%, 42.1%, 61.1%, and 78.0% at 10, 25, 50, and 100 μg/mL extract, respectively (Fig. 2A). In turn, PGE2 production was inhibited 1.5%, 69.1%, 83.2%, and 94.8% at 10, 25, 50, and 100 μg/mL extract, respectively (Fig. 2B). The inhibitory effect of S. linearis extract at 100 μg/mL on PGE2 production (94.8%), in particular, is indicative of the strong anti-inflammatory effect of the extract.

fas-25-11-579-g2
Fig. 2. Effect of Symphyocladia linearis extract (10–100 μg/mL) on NO (A) and PGE2 (B) production. RAW 264.7 cells were pretreated with different concentrations of S. linearis extract (10–100 μg/mL) and then exposed to LPS. All data are expressed as a percentage (%) of the NT. The experiment was performed in triplicate and data are represented as mean ± SD. ***p <0.001 versus the LPS-stimulated group. NT, untreated control; LPS, lipopolysaccharide; NO, nitric oxide; PGE2, prostaglandin E2.
Download Original Figure
Antibacterial activity

The S. linearis extract inhibition zones obtained using the disc diffusion method were 10 mm and 8 mm against S. aureus and B. cereus, and the MIC was 256 μg/mL and 1,024 μg/mL extract, respectively (Table 2). Our experimental results showed that the S. linearis extract had a stronger effect on gram-positive bacteria than on gram-negative bacteria.

Table 2. Paper disc diffusion assay and MIC of Symphyocladia linearis extract against four bacterial strains
Assay Escherichia coli KCTC 2571 Salmonella typhimurium KCTC 1925 Staphylococcus aureus ATCC 6538P Bacillus cereus ATCC 14579
Paper disc diffusion (mm) - - 10 8
MIC (μg/mL extract) - - 256 1,024

MIC, minimum inhibory concentration.

Download Excel Table

Discussion

The existing literature on red algae includes reports on the biological activity (anti-diabetic, antioxidant, and antiviral) and chemical composition of S. latiuscula, which is registered and used as a food ingredient in Korea. The lesser-known species S. linearis was reported as a new species in 2013 by Kang & Kim (2013); however, to our knowledge, there have been no studies on its biological activity. Therefore, in this study we investigated the antioxidant, anti-inflammatory, and antibacterial activity of a 70% EtOH extract of S. linearis.

S. linearis extract exhibited weaker antioxidant activity (considering both DPPH and ABTS) than that previously reported the IC50 value for DPPH of S. latiuscula MeOH extract was 9.03 μg/mL and the ABTS radical scavenging effect of S. latiuscula EtOH extract was 3.8% at 60 μg/mL (Cho et al., 2012; Park et al., 1998). Additionally, inhibition of ROS production by the S. linearis extract (even when assayed at a high concentration of 100 μg/mL) was ≤ 50% (Fig. 1B), whereas inhibition by the S. latiuscula extract was 50.6% at 25 μg/mL (Kang et al., 2004). These results suggest that an equivalent extract of S. linearis has lower antioxidant activity than that of S. latiuscula extract.

In the assessment of the anti-inflammatory activity of S. linearis extract, increasing inhibition of NO and PGE2 production occurred in a concentration-dependent manner. The S. linearis extract inhibited NO production > 50% at a concentration of 50 μg/mL and that of PGE2 at a concentration of 25 μg/mL extract, showing that the extract exhibited high anti-inflammatory activity. PGE2 not only serves as a mediator of the inflammatory response, but it also promotes Th2-type immune responses, suppresses Th1-type immune responses, and suppresses the production of inflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1β, and IL-8 and anti-inflammatory cytokines such as IL-10. PGE2 is known as an immune response modulator that promotes the production of cytokine (Harris et al., 2002). Our study, therefore, suggests that S. linearis could potentially be used in the prevention and treatment of inflammatory and immune diseases.

In the evaluation of the antibacterial activity of the S. linearis extract, we found that it was effective only against gram-positive bacteria (e.g., S. aureus and B. cereus), and was particularly effective against S. aureus (MIC of 256 μg/mL). S. aureus is one of the most common gram-positive bacteria that causes food poisoning in people (Rauha et al., 2000). In a previous study, a MeOH extract of S. latiuscula showed a MIC of 500 μg/mL extract for S. aureus and E. coli (Lim et al., 2000). It is difficult to compare the results because the extract types differed, MeOH vs. EtOH; however, it appears that S. linearis and S. latiuscula extracts exhibit similar antibacterial activity.

Based on our findings, we propose that a 70% EtOH extract of S. linearis has greater potential as an anti-inflammatory material than as an antioxidant or antibacterial material.

Conclusion

To the best of our knowledge, there have been no research studies on the biological activity of S. linearis; thus, we conducted experiments to assess the antioxidant, anti-inflammatory, and antibacterial properties of a 70% EtOH extract of S. linearis. Our results showed that S. linearis extract possesses strong anti-inflammatory properties, and therefore has the potential to be used in the prevention and treatment of inflammatory and immune diseases.

Competing interests

No potential conflict of interest relevant to this article was reported.

Funding sources

This work was supported by National Marine Biodiversity Institute of Korea Research Program (2022M00500).

Acknowledgements

Not applicable.

Availability of data and materials

Upon reasonable request, the datasets of this study can be available from the corresponding author.

Ethics approval and consent to participate

This article does not require IRB/IACUC approval because there are no human and animal participants.

References

1.

Al-Zoreky NS. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food Microbiol. 2009; 134:244-8

2.

Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958; 181:1199-200

3.

Cho ML, Lee DJ, You SG. Radical scavenging activity of ethanol extracts and solvent partitioned fractions from various red seaweeds. Ocean Polar Res. 2012; 34:445-51

4.

Cho W, Nam JW, Kang HJ, Windono T, Seo EK, Lee KT. Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-κB pathway in LPS-stimulated murine macrophages. Int Immunopharmacol. 2009; 9:1049-57

5.

Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol. 2002; 23:144-50

6.

Kanatt SR, Chander R, Sharma A. Antioxidant and antimicrobial activity of pomegranate peel extract improves the shelf life of chicken products. Int J Food Sci Technol. 2010; 45:216-22

7.

Kang HS, Chung HY, Kim JY, Son BW, Jung HA, Choi JS. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch Pharm Res. 2004; 27:194-8

8.

Kang JC, Kim MS. A novel species Symphyocladia glabra sp. nov. (Rhodomelaceae, Rhodophyta) from Korea based on morphological and molecular analyses. Algae. 2013; 28:149-60

9.

Lee JH. Antioxidant, antibacterial and anti-inflammatory effects of Stachys sieboldii extract. Korean J Plant Res. 2021; 34:420-32.

10.

Lee JM, Yim MJ, Kim HS, Ko SC, Kim JY, Shin JM, et al. Biological activity of flavonoids from Sonchus brachyotus. Fish Aquat Sci. 2021; 24:428-36

11.

Lim CW, Lee JS, Cho YJ. Structures and some properties of the antimicrobial compounds in the red alga, Symphyocladia latiuscula. J Korean Fish Soc. 2000; 33:280-7.

12.

Liu J, Tang J, Zuo Y, Yu Y, Luo P, Yao X, et al. Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling. Pharmacol Res. 2016; 111:303-15

13.

Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014; 2014:186864

14.

Munteanu IG, Apetrei C. Analytical methods used in determining antioxidant activity: a review. Int J Mol Sci. 2021; 22:3380

15.

Park H, Choi J, Chung H. The antioxidant activity in extracts of Symphyocladia latiuscula. J Korean Fish Soc. 1998; 31:927-32.

16.

Park HJ, Kurokawa M, Shiraki K, Nakamura N, Choi JS, Hattori M. Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice. Biol Pharm Bull. 2005; 28:2258-62

17.

Paudel P, Seong SH, Park HJ, Jung HA, Choi JS. Anti-diabetic activity of 2,3,6-tribromo-4,5-dihydroxybenzyl derivatives from Symphyocladia latiuscula through PTP1B downregulation and α-glucosidase inhibition. Mar Drugs. 2019a; 17:166

18.

Paudel P, Seong SH, Zhou Y, Park HJ, Jung HA, Choi JS. Anti-Alzheimer’s disease activity of bromophenols from a red alga, Symphyocladia latiuscula (Harvey) Yamada. ACS Omega. 2019b. 4:12259-70

19.

Paudel P, Wagle A, Seong SH, Park HJ, Jung HA, Choi JS. A new tyrosinase inhibitor from the red alga Symphyocladia latiuscula (Harvey) Yamada (Rhodomelaceae). Mar Drugs. 2019c; 17:295

20.

Rauha JP, Remes S, Heinonen M, Hopia A, Kähkönen M, Kujala T, et al. Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. Int J Food Microbiol. 2000; 56:3-12

21.

Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999; 26:1231-7

22.

Shannon E, Abu-Ghannam N. Antibacterial derivatives of marine algae: an overview of pharmacological mechanisms and applications. Mar Drugs. 2016; 14:81

23.

Wang W, Okada Y, Shi H, Wang Y, Okuyama T. Structures and aldose reductase inhibitory effects of bromophenols from the red alga Symphyocladia latiuscula. J Nat Prod. 2005; 68:620-2

24.

Xu X, Yin L, Gao J, Gao L, Song F. Antifungal bromophenols from marine red alga Symphyocladia latiuscula. Chem Biodivers. 2014; 11:807-11

25.

Yu Q, Zeng K, Ma X, Song F, Jiang Y, Tu P, et al. Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways. Int Immunopharmacol. 2016; 38:104-14

26.

Zhang WW, Duan XJ, Huang HL, Zhang Y, Wang BG. Evaluation of 28 marine algae from the Qingdao coast for antioxidative capacity and determination of antioxidant efficiency and total phenolic content of fractions and subfractions derived from Symphyocladia latiuscula (Rhodomelaceae). J Appl Phycol. 2007; 19:97-108